Ameriprise Financial Inc Intra Cellular Therapies, Inc. Transaction History

Ameriprise Financial Inc

  • $381 Billion
  • Q3 2024

A detailed history of Ameriprise Financial Inc transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Ameriprise Financial Inc holds 530,196 shares of ITCI stock, worth $46.5 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
530,196
Previous 343,821 54.21%
Holding current value
$46.5 Million
Previous $23.5 Million 64.63%
% of portfolio
0.01%
Previous 0.01%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$67.99 - $80.84 $12.7 Million - $15.1 Million
186,375 Added 54.21%
530,196 $38.8 Million
Q2 2024

Aug 14, 2024
SELL
$64.76 - $79.84 $4.43 Million - $5.46 Million
-68,375 Reduced 16.59%
343,821 $23.5 Million
Q1 2024

May 15, 2024
BUY
$64.37 - $75.65 $19.8 Million - $23.3 Million
308,009 Added 295.63%
412,196 $28.5 Million
Q4 2023

Feb 14, 2024
BUY
$46.37 - $73.65 $1.47 Million - $2.33 Million
31,667 Added 43.67%
104,187 $7.46 Million
Q3 2023

Nov 14, 2023
SELL
$52.09 - $64.1 $270,868 - $333,319
-5,200 Reduced 6.69%
72,520 $3.78 Million
Q2 2023

Aug 14, 2023
SELL
$54.67 - $66.44 $164,502 - $199,917
-3,009 Reduced 3.73%
77,720 $4.92 Million
Q1 2023

May 15, 2023
BUY
$43.8 - $56.99 $1.37 Million - $1.78 Million
31,245 Added 63.14%
80,729 $4.37 Million
Q4 2022

Feb 14, 2023
BUY
$44.07 - $54.45 $1.86 Million - $2.29 Million
42,117 Added 571.7%
49,484 $2.62 Million
Q3 2022

Nov 14, 2022
SELL
$42.7 - $59.99 $57,730 - $81,106
-1,352 Reduced 15.51%
7,367 $343,000
Q2 2022

Aug 15, 2022
BUY
$43.0 - $65.64 $53,105 - $81,065
1,235 Added 16.5%
8,719 $498,000
Q1 2022

May 16, 2022
BUY
$38.74 - $62.09 $289,930 - $464,681
7,484 New
7,484 $458,000
Q1 2020

May 15, 2020
SELL
$12.31 - $33.12 $103,231 - $277,744
-8,386 Closed
0 $0
Q4 2019

Feb 14, 2020
BUY
$7.26 - $38.49 $60,882 - $322,777
8,386 New
8,386 $288,000
Q3 2019

Nov 14, 2019
SELL
$7.47 - $14.03 $85,905 - $161,345
-11,500 Closed
0 $0
Q2 2019

Aug 14, 2019
BUY
$10.65 - $14.29 $122,475 - $164,335
11,500 New
11,500 $149,000

Others Institutions Holding ITCI

# of Institutions
377
Shares Held
85M
Call Options Held
299K
Put Options Held
130K
View Full List

About Intra-Cellular Therapies, Inc.

ITCI Quotes by TradingView
  • Ticker ITCI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 94,401,696
  • Market Cap $8.27B
  • Description
  • Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...
More about ITCI
Track This Portfolio

Track Ameriprise Financial Inc Portfolio

Follow Ameriprise Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email